This was followed by a series of studies demonstrating that “β-cell rest” or acute inhibition of insulin secretion, could restore β-cell function (first phase insulin secretion), insulin/Ca2+ pulsatility, and insulin content in obesity and T2DM (144–148). The gene discussed is INS; the disease is obesity disorder.